division_name: Health Service Medical Supplies (Costs) Bill - <i>Commons Reason</i>
motion: <p class="italic" pid="b1059.1/1" pwmotiontext="unrecognized">Moved by Lord O'Shaughnessy</p>
  
  <p class="italic" pid="b1059.1/4" pwmotiontext="unrecognized">3A: Because it would not always be appropriate to use the powers conferred on the Secretary of State to control the price of medicines and other medical supplies to promote and support the growth of the life sciences sector, and those powers cannot be exercised to ensure that patients have access to medicines and treatments.</p>
  
  <p class="italic" pid="b1063.1/1" pwmotiontext="unrecognized">Moved by Lord Warner</p>
  
  <p class="italic" pid="b1063.1/3" pwmotiontext="unrecognized">3B: Insert the following new Clause&#8212;&#8220;Duty to take account of the life sciences sector and access to new medicines and treatmentsIn discharging, through the provisions established or amended by this Act, its responsibility to secure best value for the National Health Service in purchasing medicines and medical supplies, the Government must take account of the need to&#8212;(a) promote and support a growing life sciences sector within the United Kingdom economy; and(b) ensure that patients have rapid clinical access to new clinically effective and cost-effective medicines and treatments approved by the National Institute for Health and Care Excellence through their technology appraisal process.&#8221;&#8221;</p>
  
  <p pid="b1073.0/3" pwmotiontext="yes">Ayes 245, Noes 208.</p>